Avinger, Inc.: Avinger Tigereye CTO Crossing Featured in Live Case at LINC 2021 REDWOOD CITY, CA / ACCESSWIRE / February 3, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its Tigereye CTO crossing system and Pantheris atherectomy system were featured in a live case transmission on January 29 at the Leipzig Interventional Course (LINC) 2021. LINC is a leading global forum for new methods and technology in the field of vascular medicine held each year in Leipzig, Germany. Dr. Arne Schwindt, a vascular surgeon at St. Franziskus Hospital in Münster, Germany and a pioneer in the OCT-guided treatment of vascular disease, performed the live endovascular procedure using Tigereye during a session entitled, "CTO-Crossing with New OCT-Image Guided and Steerable Catheter." The patient, a 57-year-old male, presented with severe rest pain in his leg and limited mobility with acute worsening of symptoms over the previous two years. During the case, Dr. Schwindt first safely recanalized the complete blockage in the patient's blood vessel, known as a chronic total occlusion (CTO), with Tigereye. Following the CTO crossing procedure, he used Pantheris to remove the obstructive plaque and restore blood flow to alleviate the patient's symptoms.